Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 873 | 0 | 995 | 2 | N/A |
| Inventories | N/A | 0 | N/A | 1 | 1 |
| TOTAL | $873 | $0 | $999 | $3 | $1 |
| Non-Current Assets | |||||
| Intangibles | 0 | 65 | 0 | 65 | 65 |
| Other Non-Current Assets | 4 | 0 | 4 | 0 | 0 |
| TOTAL | $4 | $65 | $4 | $65 | $65 |
| Total Assets | $877 | $65 | $1,003 | $67 | $65 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6 | 0 | 300 | 0 | 0 |
| Accrued Expenses | N/A | N/A | N/A | 21 | 20 |
| TOTAL | $10,006 | $N/A | $300 | $37 | $36 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 69 | 0 | 0 |
| TOTAL | $N/A | $N/A | $69 | $N/A | $N/A |
| Total Liabilities | $10,006 | $N/A | $369 | $37 | $36 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,161 | 1,160 | N/A | 953 | 54,593 |
| Common Shares | 209 | 65 | 3 | 55 | 55 |
| Retained earnings | -10,426 | -46 | -316 | -25 | -26 |
| Other shareholders' equity | 0 | 0 | -350 | 0 | 0 |
| TOTAL | $-9,129 | $65 | $633 | $30 | $29 |
| Total Liabilities And Equity | $876 | $65 | $1,003 | $67 | $65 |